Peter Marks, MD, PhD, director of the Food and Drug Administration (FDA)’s Center for Biologics Evaluation and Research, has issued the following statement on the agency's continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccine:
Programming a hospital's electronic health record system (EHR) to provide information on appropriate use of a costly gastrointestinal panel and to block unnecessary orders reduced inappropriate testing by 46 percent and saved up to $168,000 over 15 months, according to a study published today in
The WHO SAVE LIVES: Clean Your Hands global hand hygiene campaign, launched in 2009 and celebrated annually on May 5, features specific calls to action seeking to increase engagement from stakeholders’ collaborations in hand hygiene improvement.
The Food and Drug Administration (FDA) today issued a final rule designed to help ensure that hand sanitizers a
FDA Approves First Two-Drug Regimen for HIV-Infected Patients Who Have Never Received Antiretroviral Treatment
The Food and Drug Administration (FDA) today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated w
Citing the spread of infections linked to rising rates of opioid use across the country including HIV, viral hepatitis, skin and soft tissue infections, bone and joint infections and endocarditis, an article published in the Journal of Infectious Diseases calls on the federal government to suppor
WHO Reaffirms Commitment to Democratic Republic of the Congo as Ebola Outbreak Nears 1,000 Cases Amid Increased Violence
As the Ebola outbreak in the Democratic Republic of the Congo (DRC) approaches 1,000 cases amid increased violence, the World Health Organization (WHO) reaffirmed its commitment both to ending the outbreak and working with the government and communities to build resilient health systems.
Food and Drug Administration (FDA) commissioner Scott Gottlieb, MD, has issued the following statement on steps the agency is taking to prevent potential medical device shortages and ensure safe and effective sterilization amid shutdown of a large contract sterilization facility:
FDA commissioner Scott Gottlieb, MD, and director of FDA’s Center for Biologics Evaluation and Research Peter Marks, MD, PhD, have issued the following statement on efforts to promote and foster blood pathogen reduction technologies:
According to this week’s FluView report, while levels of outpatient flu-like illness peaked in February, overall influenza activity remains elevated, at similar levels to last week, with A(H3) viruses causing an increasing amount of the activity.